BillionToOne (BLLN) has a market capitalization of approximately $5.9B, trading at
BillionToOne's trailing twelve-month P/E ratio is 250.6x, with a price-to-book (P/B) of 11.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
BillionToOne runs a net profit margin of 7.1%, a gross margin of 70.4%, and an operating margin of 10.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
BillionToOne reported revenue of
BillionToOne does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
BillionToOne carries a debt-to-equity ratio of 0.29x and a current ratio of 10.92x, with a market beta of 0.47. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For BillionToOne (BLLN) the key facts are: market cap $5.9B, P/E 250.6x, revenue
Get BillionToOne's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.